Clinical Trials Directory

Trials / Conditions / WHO Grade II Glioma

WHO Grade II Glioma

6 registered clinical trials studyying WHO Grade II Glioma — 3 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma
NCT04458272
Daiichi Sankyo Co., Ltd.Phase 2
RecruitingChemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) G
NCT04623931
M.D. Anderson Cancer CenterPhase 2
RecruitingCustomized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Ra
NCT04479696
M.D. Anderson Cancer CenterN/A
Active Not RecruitingBGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
NCT03749187
University of California, San FranciscoPhase 1
Active Not RecruitingIntensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
NCT03251027
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
RecruitingSerial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
NCT04540107
Susan ChangPhase 1